Circulating levels of insulin‐like growth factor I ( IGF ‐I) and risk of multiple myeloma: An observational and Mendelian randomisation study
British Journal of Haematology · 2026-06 · 208 (6) · 1942-1953
DOI: 10.1111/bjh.70444 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Haematology, online erschienen am 23.03.2026. Verfasst von Yolanda Benavente und 56 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Multiple Myeloma. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, NCI NIH HHS, The Agency for Management of Universities and Research Grants (AGAUR).
Abstract (Originalsprache)
Evidence for an association between insulin‐like growth factors (IGF) and multiple myeloma (MM) is inconsistent. We examined total IGF‐I concentrations and risk of MM by combining baseline serological data among UK Biobank participants ( n = 444 187; 732 incident MM) with a two‐sample Mendelian randomisation (MR) analysis using identified genetic variants associated with circulating total IGF‐I and IGF‐binding protein 3 (IGFBP‐3) in the InterLymph consortium (2434 MM and their 2567 controls). Finally, additional lymphoid neoplasm (LN) subtypes were included for comparison with the main hypothesis. Circulating IGF‐I level was positively associated with MM risk Hazard ratio‐HR‐per one standard deviation‐SD‐increase (HR 1‐SD = 1.11, 95% confidence interval [CI]: 1.01–1.22; p ‐value = 0.03), especially closer to diagnosis. Genetically inferred IGF‐I levels were associated with increased MM risk (odds ratio [OR] = 1.27, 95% CI: 1.05–1.54) but not with any other LNs. Genetically inferred IGFBP‐3 levels showed no associations with any LN evaluated. Corroborating previous findings, in a secondary analysis, IGF‐I levels were associated with the risk of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in males with higher body mass index (HR 1‐SD in obese male = 1.36, 95% CI: 1.14–1.61). Our serological and MR analyses suggest a contributing role of IGF‐I in the susceptibility of MM; the CLL/SLL findings warrant further investigation considering sex‐specific adiposity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
- Department of Public Health, Mental Health and Maternal and Child Health Nursing, Faculty of Nursing, Universitat de Barcelona, Barcelona, Spain.
- Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
- Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
- Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Elizabeth E Brown, Mitchell J Machiela, Susan L Slager, James R Cerhan, Vincent Rajkumar, Anne J Novak, Thomas M Habermann, Gilles Salles, Michelle A T Hildebrandt, Harindra Jayasekara, Simon Cheah, Eleanor Kane, Adrien Guilloteau, Delphine Casabonne
Förderung
- Instituto de Salud Carlos III
- NCI NIH HHS
- The Agency for Management of Universities and Research Grants (AGAUR)
- World Health Organization
- Fundacio Institucio dels Centres de Recerca de Catalunya (CERCA) Program / Generalitat de Catalunya
- European Regional Development Fund (FEDER)
- The Consejería de Salud y Familia de la Junta de Andalucía
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP)
Zitieren
APA
Benavente, Y., Hermosa, S., Papadimitriou, N., Clay-Gilmour, A., Brown, E. E., Hofmann, J. N., Rothman, N., Lan, Q., Berndt, S. I., Albanes, D., Purdue, M., Machiela, M. J., Chanock, S. J., Bhatti, P., Cozen, W., Norman, A., Slager, S. L., Cerhan, J. R., Rajkumar, V., …, & Casabonne, D. (2026). Circulating levels of insulin‐like growth factor I ( IGF ‐I) and risk of multiple myeloma: An observational and Mendelian randomisation study. British Journal of Haematology, 208(6), 1942-1953. https://doi.org/10.1111/bjh.70444
Vancouver
Benavente Y, Hermosa S, Papadimitriou N, Clay-Gilmour A, Brown EE, Hofmann JN, et al. Circulating levels of insulin‐like growth factor I ( IGF ‐I) and risk of multiple myeloma: An observational and Mendelian randomisation study. British Journal of Haematology. 2026;208(6):1942-1953. doi:10.1111/bjh.70444
BibTeX
@article{Benavente2026,
author = {Benavente, Yolanda and Hermosa, Sara and Papadimitriou, Nikos and Clay-Gilmour, Alyssa and Brown, Elizabeth E and Hofmann, Jonathan N and Rothman, Nathaniel and Lan, Qing and Berndt, Sonja I and Albanes, Demetrius and Purdue, Mark and Machiela, Mitchell J and Chanock, Stephen J and Bhatti, Parveen and Cozen, Wendy and Norman, Aaron and Slager, Susan L and Cerhan, James R and Rajkumar, Vincent and Kumar, Shaji K and Vachon, Celine M and Novak, Anne J and Habermann, Thomas M and Link, Brian K and Salles, Gilles and Ghesquieres, Herve and Bracci, Paige M and Holly, Elizabeth and Griffin, Rosalie G and Hildebrandt, Michelle A T and Vermeulen, Roel C H and Kolijn, P Martijn and Hjalgrim, Henrik and Smedby, Karin Ekström and Jayasekara, Harindra and Cheah, Simon and Monnereau, Alain and Chen, Yu and Arslan, Alan and Zhang, Yawei and Camp, Nicola J and Sborov, Douglas W and Osman, Afaf E G and Ziv, Elad and De Vivo, Immaculata and Joseph, Vijai and Teras, Lauren R and Patel, Alpa V and Kane, Eleanor and Vajdic, Claire M and Guilloteau, Adrien and Cocco, Pierluigi and Alemany, Laia and Sainz, Juan and McKay, James and Birmann, Brenda M and Casabonne, Delphine},
title = {Circulating levels of insulin‐like growth factor I ( IGF ‐I) and risk of multiple myeloma: An observational and Mendelian randomisation study},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {6},
pages = {1942--1953},
doi = {10.1111/bjh.70444}
}
EUVIMED